Golden Biotechnology Corporation (GBC), founded in 2002, is a leading innovative drug discovery and evidence-based healthy food supplement manufacturing company in Taiwan, dedicated to enhancing lives by developing high quality products that prevent and treat diseases. In 2006, GBC discovered Antroquinonol® (trade name Hocena®), a small-molecule isolated from Antrodia Camphorata. Antroquinonol® and its relevant therapeutic areas have been granted more than 100 patents in 40 countries/regions worldwide for its structure, preparation method and applications in oncology, cardio-metabolic syndromes, autoimmune diseases and neurodegenerative diseases. GBC welcomes opportunities to collaborate with strategic partners in the pharmaceutical industry in further enhancing the research, development, and commercialization of Antroquinonol®.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):